Fig. 4
From: The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma
High-expressional SLC10A3 affects the prognosis of CRC patients. A The OS of CRC patients between low and high-expressional groups. B The DSS of CRC patients between low and high-expressional groups. C The PFI of CRC patients between low and high-expressional groups. D–E The survival analysis of SLC10A3 high expression and low expression in COAD and READ based on the TIMER database. F SLC10A3 expression in CRC patients was analyzed based on the tumor metastasis. G–H Nomogram to predict the COAD survival possibility among 1 year, 3 years and 5 years, including age, gender, TNM stage, tumor stage, and risk score. CRC, colorectal cancer; READ, rectal adenocarcinoma; COAD, colon adenocarcinoma. HR hazard ratio, OS overall survival, DSS disease-special survival, PFI progress-free interval